ストックスクリーナーアプリを入手
3.97
2.70%
-0.11
アフターアワーズ：
4.00
0.03
+0.76%
Nrx Pharmaceuticals Inc (NRXP) 最新ニュース
NRXP Stock Price, Quote & Chart - ChartMill
NRXP News | NRX PHARMACEUTICALS INC (NASDAQ:NRXP) - ChartMill
NRx Pharmaceuticals, Inc. (NRXP) Latest Stock News & Headlines - Yahoo Finance
5 Hot Biotech Stocks Under $5 to Buy - Insider Monkey
NRx Pharmaceuticals (NRXP) Closes Underwritten Public Offering of Common Stock At $3.50 Per Share - Insider Monkey
symbol__ Stock Quote Price and Forecast - CNN
Study finds IV ketamine shows higher remission rates than esketamine - Investing.com UK
Study finds IV ketamine shows higher remission rates than esketamine By Investing.com - Investing.com South Africa
NRx Pharmaceuticals announces proposed public stock offering - MSN
NRx Pharmaceuticals notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology. - Investing News Network
NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology. - The Manila Times
NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by - GlobeNewswire
Depression study: IV ketamine patients remitted more than nasal esketamine - Stock Titan
NRx Pharmaceuticals Announces Underwriting Agreement and Public Offering of Common Stock - Minichart
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters' Option - Investing News Network
NRx Pharmaceuticals closes $22.3M public offering - Investing.com UK
NRx Pharmaceuticals Announces $20 Million Public Stock Offering - TipRanks
NRx Pharmaceuticals closes $22.3M public offering By Investing.com - Investing.com India
NRX Pharmaceuticals Inc. announced the successful completion of its public offering of common stock, raising a total of $22.3 million. - Bitget
NRX Pharmaceuticals Closes $22.3 Million Stock Offering - marketscreener.com
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option - The Manila Times
NRx Pharmaceuticals Prices $3.50 Stock Offering to Raise ~$18.8 Million; BTIG Leads - TradingView
NRx Pharmaceuticals (NASDAQ: NRXP) closes $22.3M stock sale - Stock Titan
NRx Pharmaceuticals Closes $22.3 Million Public Offering to Support Growth and Development of CNS Therapeutics - Quiver Quantitative
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 - GlobeNewswire
Neuro stocks outpace broader markets as psychedelics, Axsome shine - BioWorld News
NRX Pharmaceuticals Prices Public Offering of 5.7 Million Shares - Moomoo
NRx Pharmaceuticals Shares Drop After $20M Public Offering Prices - Moomoo
NRx Pharmaceuticals Plans Underwritten Public Stock Offering - The Globe and Mail
NRx Pharmaceuticals (NASDAQ: NRXP) sells 5.7M shares at $3.50 - Stock Titan
NRXP: Lucid Capital Manages Successful Offering - GuruFocus
NRx Pharmaceuticals announces pricing of public offering of common stock - MSN
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock - Investing News Network
NRx Pharmaceuticals (NRXP) stock fell 19% after hours on Tuesday: Here's why - MSN
NRx Pharmaceuticals prices $20M public offering at $3.50 By Investing.com - Investing.com Australia
NRx Pharmaceuticals prices $20M public offering at $3.50 - Investing.com
NRx Pharmaceuticals Prices Public Offering of Common Stock to Raise Approximately $20 Million - Quiver Quantitative
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock - Benzinga
Biotech NRx Pharmaceuticals prices $20M stock sale for working capital - Stock Titan
NRx Pharmaceuticals Announces Proposed Public Offering of Common Stock on Nasdaq - Minichart
NRx Pharmaceuticals (NRXP) Stock Fell 19% After Hours On Tuesday: Here's Why - Benzinga
Why is NRX Pharmaceuticals stock sliding today? By Investing.com - Investing.com Canada
1.27%
1.43%
大文字化:
|
ボリューム (24 時間):